Swami U - Search Results

1

Radium-223 plus Enzalutamide Versus Enzalutamide in Metastatic Castration-Refractory Prostate Cancer: Final Safety and Efficacy Results.

Maughan BL, Kessel A, McFarland TR, Sayegh N, Nussenzveig R, Hahn AW, Hoffman JM, Morton K, Sirohi D, Kohli M, Swami U, Boucher K, Haaland B, Agarwal N. Maughan BL, et al. Among authors: swami u. Oncologist. 2021 Dec;26(12):1006-e2129. doi: 10.1002/onco.13949. Epub 2021 Sep 23. Oncologist. 2021. PMID: 34423501 Free PMC article. Clinical Trial.

2

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.

Swami U, Grivas P, Agarwal N. Swami U, et al. Oncologist. 2019 May;24(5):580-583. doi: 10.1634/theoncologist.2019-0161. Epub 2019 Mar 29. Oncologist. 2019. PMID: 30926675 Free PMC article.

3

Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement.

Swami U, Nussenzveig RH, Haaland B, Agarwal N. Swami U, et al. Ann Transl Med. 2019 Mar;7(Suppl 1):S18. doi: 10.21037/atm.2019.01.50. Ann Transl Med. 2019. PMID: 31032299 Free PMC article. No abstract available.

4

Ideal Glucocorticoid Regimen With Abiraterone Acetate: Options and Challenges.

Swami U, Pal SK, Agarwal N. Swami U, et al. JAMA Oncol. 2019 Aug 1;5(8):1167-1169. doi: 10.1001/jamaoncol.2019.1008. JAMA Oncol. 2019. PMID: 31246246 No abstract available.

5

Characterizing the Wnt Pathway in Advanced Prostate Cancer: When, Why, and How.

Pal SK, Swami U, Agarwal N. Pal SK, et al. Among authors: swami u. Eur Urol. 2020 Jan;77(1):22-23. doi: 10.1016/j.eururo.2019.06.029. Epub 2019 Jul 9. Eur Urol. 2020. PMID: 31300236 No abstract available.

6

Patterns of treatment in metastatic renal cell carcinoma for older versus younger patients.

Hahn AW, Esther J, Haaland B, Swami U, Dizman N, Rathi N, Maughan BL, Pal SK, Agarwal N. Hahn AW, et al. Among authors: swami u. J Geriatr Oncol. 2020 May;11(4):724-726. doi: 10.1016/j.jgo.2019.07.002. Epub 2019 Aug 8. J Geriatr Oncol. 2020. PMID: 31402176 No abstract available.

7

Radioisotope Imaging and Therapy for Bone Metastasis in Men With Castration-Resistant Prostate Cancer.

Swami U, Yap JT, Agarwal N. Swami U, et al. JAMA Oncol. 2020 Feb 1;6(2):225-226. doi: 10.1001/jamaoncol.2019.4635. JAMA Oncol. 2020. PMID: 31830203 No abstract available.

8

Germline variants and response to systemic therapy in advanced prostate cancer.

Johnson E, Nussenzveig R, Agarwal N, Swami U. Johnson E, et al. Among authors: swami u. Pharmacogenomics. 2020 Jan;21(1):75-81. doi: 10.2217/pgs-2019-0125. Pharmacogenomics. 2020. PMID: 31849283 Review.

9

The addition of apalutamide to ADT in the treatment of metastatic castration-sensitive prostate cancer: safety and efficacy.

Barata P, Swami U, Agarwal N. Barata P, et al. Among authors: swami u. Expert Rev Anticancer Ther. 2020 Mar;20(3):147-150. doi: 10.1080/14737140.2020.1732212. Epub 2020 Feb 24. Expert Rev Anticancer Ther. 2020. PMID: 32068456 No abstract available.

10

Advanced Prostate Cancer: Treatment Advances and Future Directions.

Swami U, McFarland TR, Nussenzveig R, Agarwal N. Swami U, et al. Trends Cancer. 2020 Aug;6(8):702-715. doi: 10.1016/j.trecan.2020.04.010. Epub 2020 Jun 10. Trends Cancer. 2020. PMID: 32534790 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters